Apollomics
APLM
10 hedge funds and large institutions have $67.8M invested in Apollomics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
741% more capital invested
Capital invested by funds: $8.06M → $67.8M (+$59.7M)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
25% more funds holding
Funds holding: 8 → 10 (+2)
1.77% more ownership
Funds ownership: 0.22% → 1.99% (+1.8%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$84.7M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$67.9K |
| 3 |
Barclays
London,
United Kingdom
|
+$4.4K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$978 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GKFF
George Kaiser Family Foundation
Tulsa,
Oklahoma
|
-$3.16M |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$61.8K |
| 3 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$14.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $67.4M | +$84.7M | +173,310 | +2,616% |
|
|
ETC
2
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| $99.7K | -$14.7K | -30 | -10% |
|
|
GKFF
3
George Kaiser Family Foundation
Tulsa,
Oklahoma
| $93.6K | -$3.16M | -6,460 | -96% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $52.2K | +$67.9K | +139 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $50.3K | – | – | – |
|
|
JJ
6
Johnson & Johnson
New Brunswick,
New Jersey
| $49.6K | – | – | – |
|
7
BlackRock
New York
| $24.6K | – | – | – |
|
|
8
Barclays
London,
United Kingdom
| $3.39K | +$4.4K | +9 | New |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$978 | +2 | New |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $749 | – | – | – |
|
|
LCS
11
Levin Capital Strategies
New York
| – | -$61.8K | -110 | Closed |
|
APLM Hedge Fund Activity: Q3 2023 in Review
10 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Apollomics (APLM) for Q3 2023, worth a combined $67.8M — up 741% from $8.06M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new APLM positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was OrbiMed, adding an estimated $84.7M. The largest seller was George Kaiser Family Foundation, cutting an estimated $3.16M.
- 10 institutional investors held Apollomics (APLM) as of Q3 2023, up from 8 in Q2 2023.
- Funds reported $67.8M of Apollomics stock for Q3 2023, up 741% quarter-over-quarter.
- 3 funds opened new Apollomics positions in Q3 2023 and 1 closed out, a net change of +2 holders.
- The largest Apollomics buyer in Q3 2023 was OrbiMed, an estimated $84.7M added.
- The largest Apollomics seller in Q3 2023 was George Kaiser Family Foundation, an estimated $3.16M sold.
Based on aggregated 13F filings for Q3 2023.